SCHEDULE 13D/A Filed 2026-10-27 Event 2026-10-26 SEC 0001104659-26-119153 →

Sealbond Ltd → Dogwood Therapeutics, Inc. DWTX

Stake: 75.20% Shares: 25,920,693 CUSIP: 92829J203 Class: Common Stock, $0.0001 par value

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 25/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -53.9%

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Active Schedule 13D filer baseline
High conviction ownership stake (75.2%)
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d
Short interest building (+60.5% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

12 transactions

8 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

62,406 shares short · +60.5% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-03-05	Grosswald Ralph	officer	Award	82,500	$2.86	$236K
2026-03-05	Walsh Angela	officer	Award	82,500	$2.86	$236K
2026-03-05	Gendreau Roger Michael	officer	Award	82,500	$2.86	$236K
2026-03-05	Duncan Gregory Scott	director, officer	Award	330,000	$2.86	$944K
2025-12-04	Duncan Gregory Scott	director, officer	Award	460,000	$6.14	$2.82M
2025-12-04	Walsh Angela	officer	Award	150,000	$6.14	$921K
2025-12-04	Grosswald Ralph	officer	Award	150,000	$6.14	$921K
2025-12-04	Gendreau Roger Michael	officer	Award	150,000	$6.14	$921K
2025-11-21	Sealbond Ltd	director, 10%+ owner	C	21,610,950	—	—
2025-11-21	Sealbond Ltd	director, 10%+ owner	C	2,842,638	—	—
2025-11-21	Sealbond Ltd	director, 10%+ owner	C	2,161.095	—	—
2025-11-21	Sealbond Ltd	director, 10%+ owner	C	284.264	—	—

Other 13D/G Filings on Dogwood Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-21	SCHEDULE 13D/A	Sealbond Ltd	72.30%	21,822,333	view →
2025-03-17	SCHEDULE	Sealbond Ltd	15.90%	211,383	view →

Other Filings by Sealbond Ltd

Filed	Form	Issuer	Stake	Shares
2026-10-21	SCHEDULE 13D/A	Dogwood Therapeutics, Inc.	72.30%	21,822,333	view →
2025-03-17	SCHEDULE	Dogwood Therapeutics, Inc. DWTX	15.90%	211,383	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →